Kadan P, Korsh O B, Melnyk A
Ukrainian Anti-Cancer Institute, Vienna, Austria.
Drugs Exp Clin Res. 1996;22(3-5):243-5.
A recurrent breast cancer with lung metastases was treated with the new anticancer drug Ukrain. The first two courses led to subjective improvement of the general condition as well as work capability; appetite improved and shortness of breath disappeared. After the sixth course of Ukrain therapy objective improvement was found clinically on X-ray, in haematological and biochemical data and improved tumour markers. Lymph nodes and lung metastases disappeared. The patient showed a full clinical remission.
一名患有肺转移的复发性乳腺癌患者接受了新型抗癌药物 Ukrain 的治疗。前两个疗程使患者的一般状况和工作能力在主观上得到改善；食欲增加，呼吸急促消失。在接受 Ukrain 治疗的第六个疗程后，通过 X 光检查、血液学和生化数据以及肿瘤标志物的改善发现了客观上的好转。淋巴结和肺转移灶消失。患者实现了完全临床缓解。
